article
Is the pharmaceutical industry good at innovation?
The prevailing view would perhaps be that the industry is not good at innovation, because it is conservative and risk averse. BPOG Director Simon Chalk shares his own views.
List view / Grid view
Issue 6 2017
article
Providing the tools and solutions
By combining Patheon’s capabilities in drug development and manufacturing with its clinical trials packaging and logistics expertise, Thermo Fisher will be able to provide an end-to-end solution for its biopharma customers. Dr John Rontree, Senior Director of Marketing, Pharmaceuticals and Biopharmaceuticals, Thermo Fisher Scientific, discusses his company’s plans.
article
The company that never stops inventing
3M’s inventions have improved daily life for hundreds of millions of people all over the world since 1902. Silvia Perez, President and General Manager of the Drug Delivery Systems (DDS) Division of 3M, highlights some of her company’s recent innovations.
article
Comprehensive solutions from a single source
The pharma sector has changed over the past 21 years, with the growth of small and large molecule drug development and the greater requirement of technology. Christian Treitel, Director Strategy and Business Development, Robert Bosch Packaging Technology, gives his insight into the ever-evolving changes and challenges of the industry, and…
article
Application Notes & Whitepapers 2017
This supplement contains a collection of application notes and whitepapers from some of the leading suppliers to the pharmaceutical industry...
article
A consistent focus on customers and their challenges
Tiffani Manolis, Director, Global Pharma Segment Marketing, Agilent Technologies, explains how her company’s solutions and portfolio have evolved with the pharma industry.
article
Biopharmaceutical Development & Processing
This In-Depth Focus looks at QbD and PAT for cutting biopharma attrition rates as well as continuous freeze-drying technology for biopharma products...
article
Looking back, looking forward
The pharmaceutical industry has seen a lot of change in the last 21 years. In 1996 the internet was relatively new and limited to computer access, mobile devices were bulky and expensive, and security concerns were primarily physical. Similarly, a lot has changed with regards to business, manufacturing and regulation,…
article
Driving growth in emerging markets
Mark Quick, Executive Vice-president, Corporate Development at Recipharm, explains how his company has set about becoming a best-in-class provider of contract development and manufacturing solutions to the pharmaceutical industry.
article
Strong partnership environment heralds success in pharma
Catalent believes it is essential to share knowledge and experience to improve understanding of drug formulation and delivery challenges and contribute jointly to finding solutions. Will Downie, Senior Vice President, Global Sales and Marketing at Catalent, explains how his company makes a success of this strategy...
article
Continuous evolution and reinvention in biopharma
Andreas Weiler, Business Unit Head for Emerging Technologies, and Fatma Senkesen, Marketing Intelligence Associate Director, at Lonza, explain how their company has kept in step with industry developments.
article
A complete set of capabilities across the entire drug continuum
Since 2014, AMRI has significantly expanded its service and product range through several acquisitions. Today, it has more than 3,100 employees at 27 locations in the US, UK, Europe and Asia, and it continues to seek new opportunities in areas of complex science. William S Marth, President and Chief Executive…
article
How pharma operations in Europe have changed in the last 25 years
Twenty five years ago, the European Community took a major step toward political and economic union by adopting the Treaty of Maastricht. The Treaty created the European Union (EU), paving the way for closer economic ties within the Union through the free movement of goods between member states. This opening…
article
Personalised medicine and partnering – key areas for Ferring
Michel Pettigrew, President of the Executive Board and Chief Operating Officer at Ferring Pharmaceuticals, explains how his company’s decentralised model and focus on entrepreneurialism is helping it to deliver personalised medicine.
article
Kyowa Kirin: Creating opportunities from challenges
Dr Masashi Miyamoto, Director of the Board, Managing Executive Officer, Director of Corporate Strategy & Planning Department at Kyowa Hakko Kirin, explains his company’s five-year mid-term plan (2016-2020) to become a global specialty pharmaceutical company, and other significant initiatives...
